trending Market Intelligence /marketintelligence/en/news-insights/trending/k_fxluqe1xq43ezypdpz8a2 content esgSubNav
In This List

Sienna Cancer Diagnostics adds board director

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation

Blog

Using Credit Analytics to Avoid Mispricing Insurance Premiums

Blog

Post-Webinar Q&A: Integrating Climate Risks into Credit Risk Portfolios


Sienna Cancer Diagnostics adds board director

Sienna Cancer Diagnostics Ltd. named Helen Fisher an independent nonexecutive director, effective March 28.

Fisher will also act as chair of the company's audit and risk committee. She was a partner at Deloitte and adviser to several life sciences and biotechnology companies, Sienna Cancer Diagnostics said in a news release.

Australia-based Sienna Cancer is a medical technology company developing and marketing innovative cancer related tests, with operations in the U.S. and Europe.